Institutional Ownership Applied Therapeutics Inc. (APLT)
This table provides information about the institutional ownership of Applied Therapeutics Inc. (APLT). We have compiled data on the 140 institutions that hold shares in the stock, with a total of 112 Million shares, which have been reported (via 13F filing form) to have a value of $997 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
10,541,528
shares
|
$93.9 Million
0.05% of portfolio
|
Q3 2024
Added 37.83%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
9,904,530
shares
|
$88.2 Million
0.01% of portfolio
|
Q3 2024
Added 181.4%
|
|
Vr Adviser, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
9,825,000
shares
|
$87.5 Million
8.65% of portfolio
|
Q3 2024
Added 2.96%
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
8,005,000
shares
|
$71.3 Million
1.78% of portfolio
|
Q1 2024
Added 96.19%
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 12, 2024 Q3 2024 |
6,800,910
shares
|
$60.6 Million
0.02% of portfolio
|
Q3 2024
Reduced 33.41%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
6,569,787
shares
|
$58.5 Million
0.0% of portfolio
|
Q2 2024
Added 564.1%
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
6,567,858
shares
|
$58.5 Million
32.38% of portfolio
|
Q2 2024
Added 7.46%
|
|
Knoll Capital Management, LLC
Miami, FL |
Nov 14, 2024 Q3 2024 |
5,574,687
shares
|
$49.7 Million
23.38% of portfolio
|
Q1 2024
Added 1.83%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
5,242,949
shares
|
$46.7 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.49%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
4,437,602
shares
|
$39.5 Million
0.02% of portfolio
|
Q3 2024
Added 89.36%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,112,361
shares
|
$36.6 Million
0.06% of portfolio
|
Q3 2024
Added 48.2%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
3,694,607
shares
|
$32.9 Million
0.0% of portfolio
|
Q3 2024
Added 123.12%
|
|
Simplify Asset Management Inc.
New York, NY |
Nov 12, 2024 Q3 2024 |
2,817,505
shares
|
$25.1 Million
1.28% of portfolio
|
Q1 2024
Added 16.55%
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
2,730,000
shares
|
$24.3 Million
1.98% of portfolio
|
Q3 2024
Added 17.17%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,091,669
shares
|
$18.6 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.34%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,746,449
shares
|
$15.6 Million
0.51% of portfolio
|
Q3 2024
Added 12.31%
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2024 Q3 2024 |
1,633,768
shares
|
$14.6 Million
0.69% of portfolio
|
Q3 2024
New holding
|
|
Stem Point Capital LP
New York, NY |
Nov 13, 2024 Q3 2024 |
1,554,586
shares
|
$13.9 Million
3.96% of portfolio
|
Q3 2024
Reduced 29.7%
|
|
Opaleye Management Inc.
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,320,000
shares
|
$11.8 Million
2.05% of portfolio
|
Q3 2024
Reduced 21.43%
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,145,000
shares
|
$10.2 Million
0.74% of portfolio
|
Q3 2024
Reduced 78.91%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,020,871
shares
|
$9.1 Million
0.0% of portfolio
|
Q3 2024
Added 3228.02%
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Nov 14, 2024 Q3 2024 |
981,673
shares
|
$8.75 Million
0.05% of portfolio
|
Q3 2024
Reduced 50.06%
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
907,294
shares
|
$8.08 Million
1.09% of portfolio
|
Q3 2024
Reduced 20.99%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
817,766
shares
|
$7.29 Million
0.0% of portfolio
|
Q3 2024
Added 436.42%
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2024 Q3 2024 |
800,000
shares
|
$7.13 Million
0.8% of portfolio
|
Q3 2024
New holding
|